IS7500A - thurrdufts samsetningar - Google Patents

thurrdufts samsetningar

Info

Publication number: IS7500A
Authority: IS; Iceland
Prior art keywords: dry powder; powder formulations; formulations; dry; powder
Prior art date: 2002-04-13

Application number

IS7500A

Other languages

English (en)

Inventor

Charles Roche Trevor

Arvind Bulsara Pallav

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-13

Filing date

2004-10-11

Publication date

2004-10-11

2004-10-11 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2004-10-11 Publication of IS7500A publication Critical patent/IS7500A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS7500A 2002-04-13 2004-10-11 thurrdufts samsetningar IS7500A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0208608.0A GB0208608D0 (en)	2002-04-13	2002-04-13	Composition
PCT/GB2003/001542 WO2003088943A1 (en)	2002-04-13	2003-04-10	Dry powder compositions

Publications (1)

Publication Number	Publication Date
IS7500A true IS7500A (is)	2004-10-11

Family

ID=9934855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7500A IS7500A (is)	2002-04-13	2004-10-11	thurrdufts samsetningar

Country Status (19)

Country	Link
US (1)	US20050244340A1 (is)
EP (1)	EP1494644A1 (is)
JP (1)	JP2005530733A (is)
KR (1)	KR20040099436A (is)
CN (1)	CN1658839A (is)
AR (1)	AR039409A1 (is)
AU (1)	AU2003217073A1 (is)
BR (1)	BR0309114A (is)
CA (1)	CA2481467A1 (is)
GB (1)	GB0208608D0 (is)
IL (1)	IL164420A0 (is)
IS (1)	IS7500A (is)
MX (1)	MXPA04010080A (is)
NO (1)	NO20044497L (is)
PL (1)	PL373294A1 (is)
RU (1)	RU2004130439A (is)
TW (1)	TW200404008A (is)
WO (1)	WO2003088943A1 (is)
ZA (1)	ZA200408245B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003024396A2 (en)	2001-09-17	2003-03-27	Glaxo Group Limited	Dry powder medicament formulations
SE526509C2 (sv) *	2003-06-19	2005-09-27	Microdrug Ag	Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
JP2009513531A (ja) *	2003-07-11	2009-04-02	グラクソグループリミテッド	糖エステルを含む吸入可能医薬製剤
WO2005004845A1 (en) *	2003-07-11	2005-01-20	Glaxo Group Limited	Pharmaceutical formulations comprising magnesium stearate
PE20060272A1 (es)	2004-05-24	2006-05-22	Glaxo Group Ltd	(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
WO2006066907A1 (en) *	2004-12-21	2006-06-29	Glaxo Group Limited	Pharmaceutical formulations
NZ556709A (en) *	2005-02-10	2009-09-25	Glaxo Group Ltd	Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
DE602007013762D1 (de)	2006-08-01	2011-05-19	Glaxo Group Ltd	Pyrazoloä3,4-büpyridinverbindungen und ihre verwendung als pde4-inhibitoren
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
KR20160003183A (ko) *	2013-04-29	2016-01-08	사노피 에스에이	흡입식 약학적 조성물 및 그를 포함하는 흡입기 장치
CN106999599B (zh) *	2014-08-01	2022-09-27	浙江悉娜医药有限责任公司	帕洛诺司琼气雾制剂及其用途
PT109030B (pt) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) *	2018-03-08	2023-06-02	润生药业有限公司	一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR8007911A (pt) *	1979-12-06	1981-06-16	Glaxo Group Ltd	Inalador aperfeicoado
SE448277B (sv) *	1985-04-12	1987-02-09	Draco Ab	Indikeringsanordning vid en doseringsanordning for lekemedel
NZ217006A (en) *	1985-07-30	1989-04-26	Glaxo Group Ltd	Inhaler for finely divided medicament includes plunger to open medicament container
GB9004781D0 (en) *	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
JPH04220268A (ja) *	1990-12-19	1992-08-11	Olympus Optical Co Ltd	バルーンカテーテル
ZA9711732B (en) *	1996-12-31	1998-12-28	Quadrant Holdings Cambridge	Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
JP2002510316A (ja) *	1997-07-03	2002-04-02	クアドラントホールディングスケンブリッジリミテッド	修飾グリコシド、これを含む組成物およびその使用方法
US6352722B1 (en) *	1997-12-23	2002-03-05	Quadrant Holdings Cambridge Limited	Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1283036B2 (de) *	1998-11-13	2020-01-01	Jagotec AG	Multidosis-Trockenpulverinhalator mit Pulverreservoir
GB9916316D0 (en) *	1999-07-12	1999-09-15	Quadrant Holdings Cambridge	Dry powder compositions
GB0015981D0 (en) *	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
GB0020616D0 (en) *	2000-08-21	2000-10-11	Quadrant Holdings Cambridge	Particulates
MXPA03004883A (es) *	2000-12-01	2004-05-04	Battelle Memorial Institute	Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas.
GB0103630D0 (en) *	2001-02-14	2001-03-28	Glaxo Group Ltd	Chemical compounds

2002
- 2002-04-13 GB GBGB0208608.0A patent/GB0208608D0/en not_active Ceased
2003
- 2003-04-10 EP EP03712461A patent/EP1494644A1/en not_active Withdrawn
- 2003-04-10 KR KR10-2004-7016302A patent/KR20040099436A/ko not_active Application Discontinuation
- 2003-04-10 BR BR0309114-7A patent/BR0309114A/pt not_active IP Right Cessation
- 2003-04-10 JP JP2003585695A patent/JP2005530733A/ja active Pending
- 2003-04-10 PL PL03373294A patent/PL373294A1/xx not_active Application Discontinuation
- 2003-04-10 CA CA002481467A patent/CA2481467A1/en not_active Abandoned
- 2003-04-10 US US10/511,042 patent/US20050244340A1/en not_active Abandoned
- 2003-04-10 MX MXPA04010080A patent/MXPA04010080A/es unknown
- 2003-04-10 AU AU2003217073A patent/AU2003217073A1/en not_active Abandoned
- 2003-04-10 WO PCT/GB2003/001542 patent/WO2003088943A1/en active Application Filing
- 2003-04-10 CN CN038137194A patent/CN1658839A/zh active Pending
- 2003-04-10 RU RU2004130439/15A patent/RU2004130439A/ru not_active Application Discontinuation
- 2003-04-11 AR ARP030101280A patent/AR039409A1/es not_active Application Discontinuation
- 2003-04-11 TW TW092108394A patent/TW200404008A/zh unknown
2004
- 2004-10-05 IL IL16442004A patent/IL164420A0/xx unknown
- 2004-10-11 IS IS7500A patent/IS7500A/is unknown
- 2004-10-12 ZA ZA200408245A patent/ZA200408245B/xx unknown
- 2004-10-21 NO NO20044497A patent/NO20044497L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200408245B (en)	2007-03-28
WO2003088943A1 (en)	2003-10-30
EP1494644A1 (en)	2005-01-12
AR039409A1 (es)	2005-02-16
JP2005530733A (ja)	2005-10-13
US20050244340A1 (en)	2005-11-03
TW200404008A (en)	2004-03-16
KR20040099436A (ko)	2004-11-26
RU2004130439A (ru)	2005-06-10
GB0208608D0 (en)	2002-05-22
AU2003217073A1 (en)	2003-11-03
IL164420A0 (en)	2005-12-18
MXPA04010080A (es)	2004-12-13
CA2481467A1 (en)	2003-10-30
CN1658839A (zh)	2005-08-24
NO20044497L (no)	2004-11-15
PL373294A1 (en)	2005-08-22
BR0309114A (pt)	2005-02-01

Publication	Publication Date	Title
DK3354263T3 (da)	2022-11-14	Tørpulverformuleringer
NO20035251D0 (no)	2003-11-26	Törrpulverinhalator
DK3494995T3 (da)	2020-03-23	Superfin formoterolformulering
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
FR2842417B1 (fr)	2005-01-21	Composition cosmetique
FR2842416B1 (fr)	2004-12-17	Composition cosmetique
IS8309A (is)	2006-02-17	Lyfjablöndur
ATE460955T1 (de)	2010-04-15	Trockenpulver-inhalator
EP1552833A4 (en)	2008-12-03	STABLE SOLID PREPARATIONS
DE60118496D1 (de)	2006-05-18	Pulverzusammensetzung
DE60311307D1 (de)	2007-03-08	Shampoo-zusammensetzungen
NO20043418L (no)	2004-08-17	Stabiliserte adenovirusformuleringer
DE60310914D1 (de)	2007-02-15	Pulverzusammensetzung
IS7501A (is)	2004-10-11	thurrdufts innöndunar samsetning
DK1561472T3 (da)	2013-11-11	Faststofsammensætning
DK1596870T3 (da)	2007-10-15	Höjdosis-iblandronatformulering
DK1539089T3 (da)	2017-11-13	Reducerede aerosol-genererende formuleringer
DE60221611D1 (de)	2007-09-20	Trockenpulverinhalator
IS7500A (is)	2004-10-11	thurrdufts samsetningar
IS7582A (is)	2004-12-03	Hraðlosandi lyfjablanda
ITMI20011532A0 (it)	2001-07-19	Cosmetico solido
DE60326900D1 (de)	2009-05-14	Duftstoff-Zusammensetzung
ATE382264T1 (de)	2008-01-15	Trockenhefe-komposition
DE60123539D1 (de)	2006-11-16	Puderquaste
GB0218194D0 (en)	2002-09-11	Solid formulations